Journals

The Rise of Biopharmaceutical Outsourcing to Indian CDMOs
Contract Services
The Rise of Biopharmaceutical Outsourcing to Indian CDMOsThe Rise of Biopharmaceutical Outsourcing to Indian CDMOs
bySiddharth J. Advant, PhD, Jaby Jacob, PhD
Jun 1, 2014
Qualification of Scale-Down Bioreactors: Validation of Process Changes in Commercial Production of Animal-Cell-Derived Products, Part 2 -- Application
Process Development
Qualification of Scale-Down Bioreactors: Validation of Process Changes in Commercial Production of Animal-Cell-Derived Products, Part 2 -- ApplicationQualification of Scale-Down Bioreactors: Validation of Process Changes in Commercial Production of Animal-Cell-Derived Products, Part 2 -- Application
byYuval Shimoni, Chetan Goudarand 2 more
Jun 1, 2014

All Journals

Enabling Greater Process Control and Higher Protein Titers: Advances in Downstream Single-Use Technologies
Separation/Purification
Enabling Greater Process Control and Higher Protein Titers: Advances in Downstream Single-Use Technologies
Enabling Greater Process Control and Higher Protein Titers: Advances in Downstream Single-Use Technologies
Jun 1, 2014
byDerek Masser
Rapid Development and Scale-Up Through Strategic Partnership: Case Study of an Integrated Approach to Cell-Line and Process Development for
Contract Services
Rapid Development and Scale-Up Through Strategic Partnership: Case Study of an Integrated Approach to Cell-Line and Process Development for Therapeutic Antibodies
Rapid Development and Scale-Up Through Strategic Partnership: Case Study of an Integrated Approach to Cell-Line and Process Development for Therapeutic Antibodies
Jun 1, 2014
+7
byKumar Dhanasekharan, Claudia Berdugo-Davisand 7 more
One Billion Mesenchymal Stem Cells in an Eppendorf BioBLU 5c Single-Use Bioreactor at 3.75-L Scale
Single Use
One Billion Mesenchymal Stem Cells in an Eppendorf BioBLU 5c Single-Use Bioreactor at 3.75-L Scale
One Billion Mesenchymal Stem Cells in an Eppendorf BioBLU 5c Single-Use Bioreactor at 3.75-L Scale
Jun 1, 2014
byDr. Ma Sha
Transformative Healthcare: The National Biomarker Development Alliance logo in a gray background | Transformative Healthcare: The National Biomarker Development Alliance
Personalized Medicine
Transformative Healthcare: The National Biomarker Development Alliance
Transformative Healthcare: The National Biomarker Development Alliance
Jun 1, 2014
byAnna D. Barker
Strategies to Mitigate Technology Transfer and Clinical Manufacturing Risks: Downstream Purification Case Studies
Risk Management
Strategies to Mitigate Technology Transfer and Clinical Manufacturing Risks: Downstream Purification Case Studies
Strategies to Mitigate Technology Transfer and Clinical Manufacturing Risks: Downstream Purification Case Studies
Jun 1, 2014
byYun Bai
June 2014 Issue Author Insights logo in a gray background | June 2014 Issue Author Insights
Business
June 2014 Issue Author Insights
June 2014 Issue Author Insights
Jun 1, 2014
byBPI Staff
Risk Management in Financing of Capital Expansions: How One CMO Grows with Its Customers
Economics
Risk Management in Financing of Capital Expansions: How One CMO Grows with Its Customers
Risk Management in Financing of Capital Expansions: How One CMO Grows with Its Customers
Jun 1, 2014
byClarke A. MacDonald
Contract Services Author Insights - June 2014 Supplement
Analytical
Contract Services Author Insights - June 2014 Supplement
Contract Services Author Insights - June 2014 Supplement
Jun 1, 2014
byBPI Staff
Development of a Single-Use Filling Needle logo in a gray background | Development of a Single-Use Filling Needle
Fill/Finish
Development of a Single-Use Filling Needle
Development of a Single-Use Filling Needle
May 1, 2014
byJean-Pascal Zambaux, James Barry
Qualification of Scale-Down Bioreactors: Validation of Process Changes in Commercial Production of Animal-Cell-Derived Products, Part 1 -- Concept logo in a gray background | Qualification of Scale-Down Bioreactors: Validation of Process Changes in Commercial Production of Animal-Cell-Derived Products, Part 1 -- Concept
Bioreactors
Qualification of Scale-Down Bioreactors: Validation of Process Changes in Commercial Production of Animal-Cell-Derived Products, Part 1 -- Concept
Qualification of Scale-Down Bioreactors: Validation of Process Changes in Commercial Production of Animal-Cell-Derived Products, Part 1 -- Concept
May 1, 2014
+2
byYuval Shimoni, Chetan Goudarand 2 more
The Benefits of Embedding Safety in Lean Practices logo in a gray background | The Benefits of Embedding Safety in Lean Practices
Analytical
The Benefits of Embedding Safety in Lean Practices
The Benefits of Embedding Safety in Lean Practices
May 1, 2014
byKim McDevitt
Quality Risk Management for Drug Products and Drug Substances logo in a gray background | Quality Risk Management for Drug Products and Drug Substances
QA/QC
Quality Risk Management for Drug Products and Drug Substances
Quality Risk Management for Drug Products and Drug Substances
May 1, 2014
byThomas A. Little
Highly Concentrated Protein Formulations: Finding Solutions for the Next Generation of Parenteral Biologics
Formulation
Highly Concentrated Protein Formulations: Finding Solutions for the Next Generation of Parenteral Biologics
Highly Concentrated Protein Formulations: Finding Solutions for the Next Generation of Parenteral Biologics
May 1, 2014
byJim Kling
Risk Management in Viral Safety logo in a gray background | Risk Management in Viral Safety
Risk Management
Risk Management in Viral Safety
Risk Management in Viral Safety
May 1, 2014
byLeah Rosin
Rapid Generation of Stable NS0 Production Cell Lines in Chemically Defined Medium logo in a gray background | Rapid Generation of Stable NS0 Production Cell Lines in Chemically Defined Medium
Manufacturing
Rapid Generation of Stable NS0 Production Cell Lines in Chemically Defined Medium
Rapid Generation of Stable NS0 Production Cell Lines in Chemically Defined Medium
May 1, 2014
byLuis M. Branco, PhD
Reference Standards for Therapeutic Proteins logo in a gray background | Reference Standards for Therapeutic Proteins
Therapeutic Modalities
Reference Standards for Therapeutic Proteins
Reference Standards for Therapeutic Proteins
May 1, 2014
byAnthony Mire- Sluis
May 2014 Issue Author Insights logo in a gray background | May 2014 Issue Author Insights
Business
May 2014 Issue Author Insights
May 2014 Issue Author Insights
May 1, 2014
byBPI Staff
Single-Use Solutions to Meet High Efficiencies in Different Cell Culture Applications
Manufacturing
Single-Use Solutions to Meet High Efficiencies in Different Cell Culture Applications
Single-Use Solutions to Meet High Efficiencies in Different Cell Culture Applications
Apr 21, 2014
byBPI Contributor
Evaluations of Extractables and Leachables in the Manufacturing of Biopharmaceutical Products
Manufacturing
Evaluations of Extractables and Leachables in the Manufacturing of Biopharmaceutical Products
Evaluations of Extractables and Leachables in the Manufacturing of Biopharmaceutical Products
Apr 21, 2014
byBPI Contributor
Development of an Automated and Disposable Platform logo in a gray background | Development of an Automated and Disposable Platform
Manufacturing
Development of an Automated and Disposable Platform
Development of an Automated and Disposable Platform
Apr 21, 2014
byBPI Contributor
Large Scale Continuous Processing in the Age of Single-Use logo in a gray background | Large Scale Continuous Processing in the Age of Single-Use
Manufacturing
Large Scale Continuous Processing in the Age of Single-Use
Large Scale Continuous Processing in the Age of Single-Use
Apr 21, 2014
byBPI Contributor
Single-Use Systems: Considerations that Extend Beyond the Bioreactor logo in a gray background | Single-Use Systems: Considerations that Extend Beyond the Bioreactor
Manufacturing
Single-Use Systems: Considerations that Extend Beyond the Bioreactor
Single-Use Systems: Considerations that Extend Beyond the Bioreactor
Apr 21, 2014
byBPI Contributor
Single-Use Perfusion for Continuous Biomanufacturing logo in a gray background | Single-Use Perfusion for Continuous Biomanufacturing
Manufacturing
Single-Use Perfusion for Continuous Biomanufacturing
Single-Use Perfusion for Continuous Biomanufacturing
Apr 21, 2014
byBPI Contributor
Progress in Single-Use Systems: Microbial, Stem Cell and Cell Culture BioProcess Scalability logo in a gray background | Progress in Single-Use Systems: Microbial, Stem Cell and Cell Culture BioProcess Scalability
Manufacturing
Progress in Single-Use Systems: Microbial, Stem Cell and Cell Culture BioProcess Scalability
Progress in Single-Use Systems: Microbial, Stem Cell and Cell Culture BioProcess Scalability
Apr 21, 2014
byBPI Contributor
Roundtable: Continuous Bioprocessing - The Next Dominant Manufacturing Platform? logo in a gray background | Roundtable: Continuous Bioprocessing - The Next Dominant Manufacturing Platform?
Manufacturing
Roundtable: Continuous Bioprocessing - The Next Dominant Manufacturing Platform?
Roundtable: Continuous Bioprocessing - The Next Dominant Manufacturing Platform?
Apr 21, 2014
byBPI Contributor
Identifying and Mitigating Risks Associated with Single-Use Tubing Set for Product Sampling and Storage Applications logo in a gray background | Identifying and Mitigating Risks Associated with Single-Use Tubing Set for Product Sampling and Storage Applications
Manufacturing
Identifying and Mitigating Risks Associated with Single-Use Tubing Set for Product Sampling and Storage Applications
Identifying and Mitigating Risks Associated with Single-Use Tubing Set for Product Sampling and Storage Applications
Apr 21, 2014
byBPI Contributor
Understanding Sources of Variation Allows Greater Control of Single-Use Bioprocesses logo in a gray background | Understanding Sources of Variation Allows Greater Control of Single-Use Bioprocesses
Manufacturing
Understanding Sources of Variation Allows Greater Control of Single-Use Bioprocesses
Understanding Sources of Variation Allows Greater Control of Single-Use Bioprocesses
Apr 21, 2014
byBPI Contributor
Integrated Single-Use Purification Technologies Enabling Continuous MAb Processing logo in a gray background | Integrated Single-Use Purification Technologies Enabling Continuous MAb Processing
Business
Integrated Single-Use Purification Technologies Enabling Continuous MAb Processing
Integrated Single-Use Purification Technologies Enabling Continuous MAb Processing
Apr 21, 2014
byBPI Contributor
Roundtable: New Approaches to Downstream Processing - Thinking Outside the Column logo in a gray background | Roundtable: New Approaches to Downstream Processing - Thinking Outside the Column
Manufacturing
Roundtable: New Approaches to Downstream Processing - Thinking Outside the Column
Roundtable: New Approaches to Downstream Processing - Thinking Outside the Column
Apr 21, 2014
byBPI Contributor
Controlling Particulate Through a Supply Chain logo in a gray background | Controlling Particulate Through a Supply Chain
Manufacturing
Controlling Particulate Through a Supply Chain
Controlling Particulate Through a Supply Chain
Apr 21, 2014
byBPI Contributor
Harmonization of Single-Use Systems: Coordination of SUS Standards and Best Practice Efforts logo in a gray background | Harmonization of Single-Use Systems: Coordination of SUS Standards and Best Practice Efforts
Manufacturing
Harmonization of Single-Use Systems: Coordination of SUS Standards and Best Practice Efforts
Harmonization of Single-Use Systems: Coordination of SUS Standards and Best Practice Efforts
Apr 21, 2014
byBPI Contributor
Process Requirements Met with Single-Use Pumps logo in a gray background | Process Requirements Met with Single-Use Pumps
Manufacturing
Process Requirements Met with Single-Use Pumps
Process Requirements Met with Single-Use Pumps
Apr 21, 2014
byBPI Contributor
High–Cell-Density Clarification By Single-Use Diatomaceous Earth Filtration logo in a gray background | High–Cell-Density Clarification By Single-Use Diatomaceous Earth Filtration
Single Use
High–Cell-Density Clarification By Single-Use Diatomaceous Earth Filtration
High–Cell-Density Clarification By Single-Use Diatomaceous Earth Filtration
Apr 1, 2014
+2
byBenjamin Minow, Florian Egnerand 2 more

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Big Impact from Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis
Register Now: Big Impact from Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis
Ask the Expert webcasts
ATE Webcasts
Register Now: Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics
Register Now: Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics
Insider News
See all
Jun 5 - Jun 6, 2024
Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization
Learn More

Innovative Technology

Nagase Trehalose SG
Sponsored Content
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG

Jan 9, 2025

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Thermo Fisher White Paper
Sponsored Content
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies

Nov 21, 2024

Subscribe and receive the latest insights on the healthy food and beverage industry.
Join 47,000+ member. Yes, it's completely free.
Sign Me Up